ATE370733T1 - Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzen - Google Patents

Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzen

Info

Publication number
ATE370733T1
ATE370733T1 AT04726223T AT04726223T ATE370733T1 AT E370733 T1 ATE370733 T1 AT E370733T1 AT 04726223 T AT04726223 T AT 04726223T AT 04726223 T AT04726223 T AT 04726223T AT E370733 T1 ATE370733 T1 AT E370733T1
Authority
AT
Austria
Prior art keywords
spasticity
treatment
pain
pharmaceutical combination
combination preparation
Prior art date
Application number
AT04726223T
Other languages
English (en)
Inventor
Karoly Tihanyi
Pal Kocsis
Gyoergy Nemeth
Istvan Tarnawa
Balazs Dalmadi
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of ATE370733T1 publication Critical patent/ATE370733T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4453Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04726223T 2003-04-09 2004-04-07 Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzen ATE370733T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0300929A HUP0300929A3 (en) 2003-04-09 2003-04-09 Analgetic and/or muscle relaxant pharmaceutical composition

Publications (1)

Publication Number Publication Date
ATE370733T1 true ATE370733T1 (de) 2007-09-15

Family

ID=90001682

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04726223T ATE370733T1 (de) 2003-04-09 2004-04-07 Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzen

Country Status (16)

Country Link
US (1) US20060199841A1 (de)
EP (1) EP1610785B1 (de)
JP (1) JP2006522786A (de)
AT (1) ATE370733T1 (de)
CY (1) CY1106903T1 (de)
DE (1) DE602004008440T2 (de)
DK (1) DK1610785T3 (de)
EA (1) EA007732B1 (de)
ES (1) ES2293245T3 (de)
HR (1) HRP20070441T3 (de)
HU (1) HUP0300929A3 (de)
NO (1) NO20055254L (de)
PL (1) PL1610785T3 (de)
PT (1) PT1610785E (de)
RS (1) RS20050738A (de)
WO (1) WO2004089352A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1395289T3 (da) * 2001-06-07 2011-03-28 Christine Dr Sang Behandling af neuropatisk smerte med en N-methyl-D-aspartat- (NMDA-)receptorantagonist
US8262942B2 (en) 2008-02-07 2012-09-11 The George Washington University Hollow carbon nanosphere based secondary cell electrodes
TR201720289A2 (tr) * 2017-12-13 2019-06-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Tolperizon Ve Selektif COX-2 İnhibitörü Kombinasyonları
JP7169580B2 (ja) * 2018-09-27 2022-11-11 株式会社Lttバイオファーマ 線維症治療用医薬組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5340779A (en) * 1976-09-21 1978-04-13 Nippon Kayaku Co Ltd Optically active tolpertisone, their preparation and pharmaceuticals containting the same
AU2929489A (en) * 1987-12-22 1989-07-19 John W. FERKANY Dextrorphan potentiator for anticonvulsant composition and method
US4906638A (en) * 1987-12-22 1990-03-06 Nova Pharmaceutical Corporation Dextromethorphan potentiator for anticonvulsant composition and method
US5206248A (en) * 1992-03-27 1993-04-27 Smith Richard A Method for reducing emotional lability
EP1634597A1 (de) * 1994-09-22 2006-03-15 Richard Alan Smith Dextromethorphan und Quinidin oder Quinine enthaltende Zusammensetzungen zur Behandlung der Gemütslabilität
US5840731A (en) * 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
CA2264182A1 (en) * 1996-08-23 1998-02-26 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
AT409083B (de) * 1999-04-01 2002-05-27 Sanochemia Pharmazeutika Ag Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
DE10123129A1 (de) * 2001-05-02 2002-11-14 Berolina Drug Dev Ab Svedala Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
DE602004008440T2 (de) 2008-05-21
CY1106903T1 (el) 2012-09-26
ES2293245T3 (es) 2008-03-16
HUP0300929A2 (hu) 2005-02-28
NO20055254L (no) 2006-01-06
WO2004089352A2 (en) 2004-10-21
DK1610785T3 (da) 2007-10-22
NO20055254D0 (no) 2005-11-08
EA200501591A1 (ru) 2006-06-30
DE602004008440D1 (de) 2007-10-04
HUP0300929A3 (en) 2005-06-28
EP1610785A2 (de) 2006-01-04
HUP0300929D0 (en) 2003-06-28
US20060199841A1 (en) 2006-09-07
EP1610785B1 (de) 2007-08-22
JP2006522786A (ja) 2006-10-05
HRP20070441T3 (en) 2007-10-31
PL1610785T3 (pl) 2008-01-31
PT1610785E (pt) 2007-09-10
EA007732B1 (ru) 2006-12-29
RS20050738A (en) 2008-04-04
WO2004089352A3 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
GB0022438D0 (en) Organic Compounds
TW200615266A (en) Organic compounds
ATE457027T1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
DE502005008058D1 (de) Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen
ATE433450T1 (de) Substituierte 1,4,8-triazaspiro 4.5 decan-2-on- verbindungen
ATE502631T1 (de) Verbindungen zur behandlung von stoffwechselstörungen
NO20055254D0 (no) Farmasoytisk kombinasjon for behandling av spastisitet og/eller smerte
GB0012795D0 (en) Organic compounds
DE602004029993D1 (de) Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit
MY136965A (en) 1,4-disubstituted piperidine compounds, their preparation and use as medicaments
DE502007006951D1 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
ATE543495T1 (de) Pharmazeutische zusammensetzung mit einer ruthenium-oxalato-verbindung und anwendungsverfahren dafür
UA81405C2 (en) Substituted pyridinones as modulators of p38 map kinase
ATE401081T1 (de) Ammoniumsalze von ornithin-derivaten zur behandlung von enzündlichen erkrankungen
IS6416A (is) Fjórgild ammóníum og notkun þeirra sem miðlar gegn hósta
TH62500A (th) Nk1 แอนทาโกนิสท์

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1610785

Country of ref document: EP

REN Ceased due to non-payment of the annual fee